Life360 Valuation

Is LIFX undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of LIFX when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: LIFX ($13.91) is trading below our estimate of fair value ($19.18)

Significantly Below Fair Value: LIFX is trading below fair value by more than 20%.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for LIFX?

Key metric: As LIFX is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for LIFX. This is calculated by dividing LIFX's market cap by their current revenue.
What is LIFX's PS Ratio?
PS Ratio8.9x
SalesUS$342.92m
Market CapUS$3.06b

Price to Sales Ratio vs Peers

How does LIFX's PS Ratio compare to its peers?

The above table shows the PS ratio for LIFX vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average16.7x
YOU Clear Secure
3.4x10.8%US$3.6b
SOUN SoundHound AI
45.3x54.7%US$3.1b
BRZE Braze
7.4x16.9%US$4.0b
ESMT EngageSmart
10.6x20.5%US$3.9b
LIFX Life360
8.9x16.5%US$4.7b

Price-To-Sales vs Peers: LIFX is good value based on its Price-To-Sales Ratio (8.9x) compared to the peer average (16.7x).


Price to Sales Ratio vs Industry

How does LIFX's PS Ratio compare vs other companies in the US Software Industry?

80 CompaniesPrice / SalesEstimated GrowthMarket Cap
VYX NCR Voyix
0.6x-23.2%US$2.12b
PGY Pagaya Technologies
0.7x15.8%US$704.88m
0.6x1.1%US$397.21m
XPER Xperi
0.8x1.8%US$390.47m
LIFX 8.9xIndustry Avg. 5.3xNo. of Companies80PS048121620+
80 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: LIFX is expensive based on its Price-To-Sales Ratio (8.9x) compared to the US Software industry average (5.3x).


Price to Sales Ratio vs Fair Ratio

What is LIFX's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

LIFX PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio8.9x
Fair PS Ration/a

Price-To-Sales vs Fair Ratio: Insufficient data to calculate LIFX's Price-To-Sales Fair Ratio for valuation analysis.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst LIFX forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentUS$13.91
US$15.68
+12.7%
10.9%US$17.59US$11.72n/a8
Nov ’25US$14.00
US$14.17
+1.2%
13.1%US$17.77US$11.52n/a8
Oct ’25US$10.94
US$14.02
+28.1%
6.4%US$15.11US$12.10n/a8
Sep ’25US$11.98
US$13.18
+10.1%
5.7%US$14.16US$11.53n/a8
Aug ’25US$11.75
US$11.50
-2.1%
7.7%US$12.51US$10.16n/a8
Jul ’25US$10.60
US$11.01
+3.8%
5.0%US$11.81US$10.32n/a8
Jun ’25US$9.30
US$10.95
+17.7%
5.0%US$11.73US$10.24n/a8
May ’25US$8.61
US$10.03
+16.5%
6.8%US$11.08US$9.02n/a8
Apr ’25US$8.47
US$9.10
+7.5%
6.6%US$9.88US$7.82n/a8
Mar ’25US$5.39
US$7.73
+43.5%
18.9%US$9.40US$5.69n/a8
Feb ’25US$4.85
US$6.97
+43.7%
11.7%US$8.00US$5.73n/a8
Jan ’25US$4.85
US$6.96
+43.5%
12.2%US$8.04US$5.76n/a8
Dec ’24US$4.90
US$6.96
+42.1%
12.2%US$8.04US$5.76n/a8
Nov ’24US$4.76
US$7.09
+49.2%
12.5%US$8.88US$6.03US$14.006
Oct ’24US$5.63
US$7.10
+26.1%
12.8%US$9.03US$6.12US$10.946
Sep ’24US$6.56
US$7.08
+8.0%
13.0%US$9.07US$6.15US$11.986
Aug ’24US$5.47
US$6.24
+14.1%
10.1%US$7.30US$5.32US$11.755
Jul ’24US$4.89
US$6.09
+24.6%
11.7%US$7.45US$5.43US$10.605
Jun ’24n/a
US$6.12
0%
11.4%US$7.30US$5.56US$9.304
May ’24n/a
US$6.05
0%
13.2%US$7.37US$5.26US$8.614
Apr ’24n/a
US$6.05
0%
13.2%US$7.37US$5.26US$8.474
Mar ’24n/a
US$6.61
0%
19.5%US$8.79US$5.49US$5.394
Feb ’24US$4.00
US$6.61
+65.3%
19.5%US$8.79US$5.49US$4.854
Jan ’24US$3.42
US$6.50
+90.1%
21.2%US$8.82US$5.21US$4.854
Dec ’23US$4.49
US$6.48
+44.4%
19.1%US$8.61US$5.62US$4.904
Nov ’23US$3.98
US$6.09
+53.0%
21.3%US$8.22US$4.79US$4.764

Analyst Forecast: Target price is less than 20% higher than the current share price.


Discover undervalued companies